Skip to main content
. 2023 Jan 18;14:1103429. doi: 10.3389/fendo.2023.1103429

Table 1.

Demographic and clinical characteristics comparing small cell carcinoma of the ovary and high-grade serous ovarian cancer.

Subject Characteristic Before propensity score matching P-value After propensity score matching SD
HGSOC SCCO HGSOC SCCO
N(%) N(%) N(%) N(%)
All 31979 206 628 181
Year of diagnosis
2000-2001 3117 (9.7) 21 (10.2) 0.851 66 (10.5) 18 (9.9) 0.052
2002-2015 24880 (77.8) 157 (76.2) 486 (77.4) 138 (76.2)
2016-2017 3982 (12.5) 28 (13.6) 76 (12.1) 25 (13.8)
Laterality
Bilateral 16313 (51.0) 27 (13.1) <0.001 92 (14.6) 27 (14.9) 0.06
Left 6003 (18.8) 73 (35.4) 221 (35.2) 61 (33.7)
Only one side - side unspecified 290 (0.9) 3 (1.5) 8 (1.3) 3 (1.7)
Paired site, but no information concerning laterality 3038 (9.5) 18 (8.7) 69 (11.0) 18 (9.9)
Right 6335 (19.8) 85 (41.3) 238 (37.9) 72 (39.8)
Surgery status
No surgery 3492 (10.9) 43 (20.9) <0.001 136 (21.7) 41 (22.7) 0.024
Surgery 28447 (89.0) 163 (79.1) 492 (78.3) 140 (77.3)
Unknown 40 (0.1) 0 (0.0) 0 (0.0) 0 (0.0)
Radiation therapy
No radiation 31709 (99.2) 192 (93.2) <0.001 607 (96.7) 177 (97.8) 0.069
Radiation 270 (0.8) 14 (6.8) 21 (3.3) 4 (2.2)
Chemotherapy status
Chemotherapy 6676 (20.9) 50 (24.3) 0.267 168 (26.8) 48 (26.5) 0.005
No chemotherapy/Unknown 25303 (79.1) 156 (75.7) 460 (73.2) 133 (73.5)
Number of primary tumors
1st of 2 or more primaries 2453 (7.7) 12 (5.8) 0.389 42 (6.7) 12 (6.6) 0.002
One primary only 29526 (92.3) 194 (94.2) 586 (93.3) 169 (93.4)
Race
Black 2182 (6.8) 16 (7.8) 0.225 38 (6.1) 16 (8.8) 0.116
Other (American Indian/AK Native, Asian/Pacific Islander) 2526 (7.9) 18 (8.7) 54 (8.6) 17 (9.4)
Unknown 85 (0.3) 2 (1.0) 5 (0.8) 1 (0.6)
White 27186 (85.0) 170 (82.5) 531 (84.6) 147 (81.2)
Marital status at diagnosis
DSW 8794 (27.5) 30 (14.6) <0.001 113 (18.0) 28 (15.5) 0.089
Married 16988 (53.1) 79 (38.3) 264 (42.0) 74 (40.9)
Single 4997 (15.6) 90 (43.7) 226 (36.0) 72 (39.8)
Unknown 1200 (3.8) 7 (3.4) 25 (4.0) 7 (3.9)
Median household income ($)
<50,000 3542 (11.1) 35 (17.0) <0.001 106 (16.9) 29 (16.0) 0.036
>=70,000 13766 (43.0) 63 (30.6) 207 (33.0) 58 (32.0)
50,000-69,999 14671 (45.9) 108 (52.4) 315 (50.2) 94 (51.9)
Age (years)
<=51 6532 (20.4) 141 (68.4) <0.001 354 (56.4) 116 (64.1) 0.165
>=74 6844 (21.4) 23 (11.2) 107 (17.0) 23 (12.7)
52-73 18603 (58.2) 42 (20.4) 167 (26.6) 42 (23.2)
Grade
I/II 4524 (14.1) 1 (0.5) <0.001 8 (1.3) 1 (0.6) 0.083
III/IV 20364 (63.7) 107 (51.9) 327 (52.1) 92 (50.8)
Unknown 7091 (22.2) 98 (47.6) 293 (46.7) 88 (48.6)
Seer stage
Distant 24812 (77.6) 122 (59.2) <0.001 406 (64.6) 114 (63.0) 0.051
Localized 1706 (5.3) 26 (12.6) 68 (10.8) 19 (10.5)
Regional 4933 (15.4) 53 (25.7) 140 (22.3) 43 (23.8)
Unknown 528 (1.7) 5 (2.4) 14 (2.2) 5 (2.8)
Stage
I 2771 (8.7) 44 (21.4) <0.001 105 (16.7) 31 (17.1) 0.086
II 2269 (7.1) 15 (7.3) 51 (8.1) 14 (7.7)
III 15489 (48.4) 65 (31.6) 224 (35.7) 58 (32.0)
IV 9140 (28.6) 62 (30.1) 188 (29.9) 59 (32.6)
Unknown 2310 (7.2) 20 (9.7) 60 (9.6) 19 (10.5)
tumor size (mm)
<=92 11859 (37.1) 38 (18.4) <0.001 136 (21.7) 37 (20.4) 0.1
>=141 3108 (9.7) 79 (38.3) 176 (28.0) 59 (32.6)
93-140 5081 (15.9) 42 (20.4) 141 (22.5) 38 (21.0)
Unknown 11931 (37.3) 47 (22.8) 175 (27.9) 47 (26.0)
Lymph nodes status
negative 7586 (23.7) 59 (28.6) 0.18 177 (28.2) 46 (25.4) 0.063
positive 7094 (22.2) 38 (18.4) 113 (18.0) 34 (18.8)
Unknown 17299 (54.1) 109 (52.9) 338 (53.8) 101 (55.8)
CA125
negative 1283 (4.0) 18 (8.7) <0.001 41 (6.5) 16 (8.8) 0.095
positive 19475 (60.9) 92 (44.7) 291 (46.3) 85 (47.0)
Unknown 11221 (35.1) 96 (46.6) 296 (47.1) 80 (44.2)